| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
3,010 |
423 |
$222K |
| 80053 |
Comprehensive metabolic panel |
7,938 |
5,641 |
$158K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,351 |
787 |
$77K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,007 |
4,785 |
$69K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,341 |
962 |
$68K |
| 90832 |
Psychotherapy, 30 minutes with patient |
705 |
148 |
$41K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,937 |
1,499 |
$33K |
| 80061 |
Lipid panel |
3,897 |
2,912 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
175 |
139 |
$27K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
996 |
858 |
$27K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,869 |
2,072 |
$22K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,136 |
746 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
1,139 |
844 |
$21K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
907 |
699 |
$19K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
506 |
379 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
329 |
304 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,084 |
1,618 |
$15K |
| 85027 |
|
2,154 |
1,629 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
825 |
632 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,866 |
1,272 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
304 |
210 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
522 |
356 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
874 |
603 |
$8K |
| 80050 |
General health panel |
155 |
152 |
$7K |
| 81001 |
|
2,219 |
1,600 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,416 |
1,083 |
$7K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
336 |
234 |
$6K |
| 83880 |
|
470 |
330 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
698 |
521 |
$5K |
| 87070 |
|
528 |
412 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
74 |
54 |
$5K |
| 94760 |
|
590 |
380 |
$5K |
| 84484 |
|
792 |
533 |
$4K |
| 82570 |
|
628 |
508 |
$4K |
| 82043 |
|
820 |
646 |
$4K |
| 83690 |
|
506 |
369 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
12 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
213 |
163 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
212 |
175 |
$2K |
| 80051 |
|
95 |
64 |
$2K |
| 86710 |
|
151 |
113 |
$2K |
| 82728 |
|
226 |
174 |
$2K |
| 82607 |
|
178 |
129 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
15 |
12 |
$2K |
| 73562 |
|
55 |
38 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
314 |
234 |
$1K |
| 87186 |
|
224 |
179 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
70 |
12 |
$1K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
82 |
76 |
$960.42 |
| 83540 |
|
182 |
143 |
$747.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
527 |
441 |
$707.88 |
| 72100 |
|
17 |
14 |
$687.97 |
| 82553 |
|
70 |
50 |
$647.25 |
| 81025 |
|
79 |
63 |
$613.98 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
67 |
54 |
$562.94 |
| 87077 |
|
15 |
12 |
$526.35 |
| 84520 |
|
135 |
92 |
$511.46 |
| 84439 |
|
42 |
36 |
$365.29 |
| 82550 |
|
87 |
62 |
$310.77 |
| 84450 |
|
101 |
77 |
$292.54 |
| 81003 |
|
108 |
89 |
$280.17 |
| 82310 |
|
98 |
64 |
$269.44 |
| 82947 |
|
94 |
63 |
$218.40 |
| 84155 |
|
75 |
54 |
$214.26 |
| 82247 |
|
75 |
54 |
$198.23 |
| 84075 |
|
75 |
54 |
$196.41 |
| 99497 |
|
79 |
74 |
$182.64 |
| 84460 |
|
75 |
54 |
$162.24 |
| 82040 |
|
75 |
54 |
$134.52 |
| 83735 |
|
52 |
28 |
$95.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
55 |
40 |
$66.65 |
| 90686 |
|
40 |
33 |
$55.12 |
| 0001A |
|
13 |
13 |
$16.94 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
35 |
30 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
40 |
33 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
39 |
36 |
$0.00 |
| 0002A |
|
13 |
13 |
$0.00 |